News

Filter

Current filters:

tacrolimusSandoz

1 to 9 of 22 results

Novartis expands transplant portfolio with first branded generic tacrolimus

04-04-2012

Swiss drug major Novartis has announced the US introduction and availability of Hecoria (tacrolimus)…

Astellas PharmaGenericsHecoriaImmunologicalsMarkets & MarketingNorth AmericaNovartisPrografSandoztacrolimus

US court rejects Astellas’ appeal on generic immunosuppressants

14-09-2009

The US District Court in Washington DC has denied the Temporary Restraining Order and Preliminary Injunction…

Asia-PacificGenericsImmunologicalsNorth AmericaNovartisNystatinOralPrografProtopicSandoztacrolimus

Astellas Announces the Outcome of its Citizen Petition in the USA

11-08-2009

Japan’s Astellas Pharma says that its North American affiliate has received notice that the US.…

Asia-PacificAstellas PharmaImmunologicalsNorth AmericaNovartisNystatinOralPharmaceuticalPrografProtopicSandoztacrolimus

Prograf Linked To Cardiotoxicity?

17-04-1995

Fujisawa's new immunosuppressant drug Prograf (tacrolimus) has been linked to five cases of cardiotoxicity…

CyclosporineNeoralPrografProtopicSandoztacrolimus

FDA Panel Backs Cellcept For Acute Rejection

10-04-1995

Syntex' new-generation immunosuppressant drug, Cellcept (mycophenolate mofetil), should be approved for…

AzasanazathioprineBristol-Myers SquibbCellCeptCyclosporineExelonImuranMycophenolate MofetilNeoralPrografProtopicRapamuneRivastigmine TartrateSandozsirolimustacrolimus

Second European Launch For Prograf

10-04-1995

Fujisawa Pharmaceuticals will launch its immunosuppresive agent Prograf (tacrolimus) in Germany on April…

PrografProtopicSandoztacrolimus

1 to 9 of 22 results

Back to top